1184
We conclude that low-dose HU therapy in patients with thalassemia intermedia may increase total Hb levels sufficiently to eliminate the need for transfusions.
 ( potential therapeutic event: therapy ,  in patients with thalassemia intermedia: Subject, increase total Hb levels: Effect, low-dose HU therapy: Treatment, thalassemia intermedia: Treatment.Disorder, HU: Treatment.Drug, low-dose: Treatment.Dosage) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( potential therapeutic event: therapy ,  in patients with thalassemia intermedia: Subject, increase total Hb levels: Effect, low-dose HU therapy: Treatment, thalassemia intermedia: Treatment.Disorder, HU: Treatment.Drug, low-dose: Treatment.Dosage) 